Results 191 to 200 of about 1,574,238 (214)

Ligand Reorganization for End-Point Binding Free Energy Calculations: Identifying Preferred Poses of Fentanyls in the μ Opioid Receptor. [PDF]

J Chem Theory Comput
Minh DDL, Cooper DA, Xie B, Shi L.
europepmc   +1 more source

Discovery of Novel pH-Sensitive μ-Opioid Receptor Agonists as Potent Analgesics with Reduced Side Effects. [PDF]

ACS Med Chem Lett
Wang Z, Li ZZ, Han XM, Dong J, Yin MY, Song J, Zhuang T, Wang Y.   +7 more
europepmc   +1 more source

Potency, dissociation kinetics and reversibility of fentanyls and nitazenes by naloxone at the μ opioid receptor

Alhosan N, Cavallo D, Santiago M, Kelly E, Henderson G.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Team Approach for Nonmedical Opioid Use

Ca-A Cancer Journal for Clinicians, 2023
Mike Fillon
exaly  

Systemic Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Stage and Metastatic Breast Cancer

Ca-A Cancer Journal for Clinicians, 2023
Hope Rugo, Özge Gümüşay, Laura A Huppert   +2 more
exaly  

Critical Care Management of Chimeric Antigen Receptor T-Cell Therapy Recipients

Ca-A Cancer Journal for Clinicians, 2022
Sandrine Valadè, Peter Schellongowski, Alexander Shimabukuro-Vornhagen   +2 more
exaly  

Structures of the Entire Human Opioid Receptor Family

Cell, 2023
Huaqiang Xu, Qingning Yuan
exaly  

Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma: A Comprehensive Review of Current Data and Implications for Clinical Practice

Ca-A Cancer Journal for Clinicians, 2023
Sagar Lonial, Rujul Parikh
exaly  

Epigenetic Regulation of Toll-Like Receptor Signaling: Implications for Cancer Development

Medical Epigenetics, 2013
Sherine F Elsawa
exaly